Education
About Us
Working with TipRanks
Follow Us
David R Pelizzon Insider Profile
4 Followers
David R Pelizzon, Director at OrthoPediatrics, holds 11.73M shares in Alphatec Holdings (Ticker: ATEC), holds 6.93M shares in OrthoPediatrics (Ticker: KIDS). Most recently, David R Pelizzon Bought ― shares of Alphatec Holdings on Aug 26, 2024 for an estimated value of 150.00K.
Profitable Transactions
4 out of 11 Profitable Transactions
Average Return
+12.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David R Pelizzon holds in companies
Most Profitable Insider Trade
The most profitable trade made by David R Pelizzon
David R Pelizzon's Trading History
OrthoPediatrics
May 30, 2024
Director
Uninformative Buy
―
$175.58M
Alphatec Holdings
Aug 26, 2024
Director, Ten Percent Owner
Informative Buy
150.00K
$122.66M
List of latest transactions for each holding click on a transaction to see David R Pelizzon's performance on stock
You May Also Like
David R Pelizzon insider profile FAQ
What is the percentage of profitable transactions made by David R Pelizzon?
The percentage of profitable transactions made by David R Pelizzon is 36%.
What is the average return per transaction made by David R Pelizzon?
The average return per transaction made by David R Pelizzon is 12.60%.
What stocks does David R Pelizzon hold?
David R Pelizzon holds: KIDS, ATEC stocks.
What was David R Pelizzon’s latest transaction?
David R Pelizzon latest transaction was an Informative Buy of $150.00K.
What was David R Pelizzon's most profitable transaction?
David R Pelizzon’s most profitable transaction was an Informative Buy of KIDS stock on March 13, 2018. The return on the trade was 133.60%.
What is David R Pelizzon's role in OrthoPediatrics?
David R Pelizzon's role in OrthoPediatrics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.